Cargando…
Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
Autores principales: | de Montmollin, Etienne, Faille, Dorothée, Andrieu, Valérie, Ajzenberg, Nadine, Timsit, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862021/ https://www.ncbi.nlm.nih.gov/pubmed/33549626 http://dx.doi.org/10.1016/j.jinf.2021.02.003 |
Ejemplares similares
-
Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020) -
Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients
por: Timsit, Jean-François, et al.
Publicado: (2022) -
Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010) -
Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing
por: Engelen, Matthias M., et al.
Publicado: (2022) -
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)